Contract Research
To list your Organisation. Please email us and we will send you a confirmation/order form.
North & Latin America
* Advanced Clinical Research
* Algorithme Pharma
* Allied Clinical Research
* Alquest, Inc.
* Amarex Clinical Research
* Anapharm
* Arkios BioDevelopment Intnl
* ARS, Inc.
* Atlantic Life Sciences Quebec
* Averion Inc.
* BioClin Health Research
* Biovail Contract Research
* BRI Biopharmaceutical Research Inc.
* Carolinas Research Associates
* Cato Research
* CCS Associates, Inc.
* Cellular Technology Ltd.
* Center for Health Services Research
* A CentraLabS Clinical Research
* Chiltern International
* Cirion Biopharma Research
* Clinical Assistance Programs
* Clinical Research Consulting, Inc.
* Clinical Supplies Management Inc.
* Clinimetrics Research Associates
* ClinStat, Inc.
* Covance
* CPIC Latin America
* C.R.O.Cont(r)acts
* CroMedica Group of Medicines Development
* CTO Clinical Trial Operations b.v. Netherlands
* DermTech International
* Emissary, Inc.
* GENTIAE Clinical Research
* Grayline Clinical Drug Trials
* Gulf Coast Research Associates, Inc.
* ICON Clinical Research
* INC Research
* InfoQuest
* Ingenix Pharmaceutical Services
* International Drug Development Institute (IDDI)
* Inveresk Research International, Ltd.
* KAI
* Kriger Research Group International
* Kriger Research Center Inc - USA
* Kriger Research Center Inc - Canada
* Marshall-Blum
* MAT & ASOC.
* Millenix, Inc.
* Moncoa Medical Research Inc.
* MonitorForHire.com
* NCGS Laboratories, Inc.
* Neuromorphometrics
* New Brunswick Scientific
* New Drug Services
* Northwest Kinetics
* Norwich Clinical Research Associates Ltd
* Novum Pharmaceutical Research Services
* Omnicare Clinical Research
* Operatrix Consulting Inc.
* P3 Research, Ltd.
* PeachTree Clinical Research, LLC.
* Pharmaceutical Consultants, Inc.
* PharmaLinkFHI
* Pharmatek Laboratories, Inc.
* Piedmont Consulting Group, LLC
* Pinnacle Research Group, LLC
* Premier Research
* Prevalere Life Sciences, Inc.
* Quantum Clinical Research
* Quintiles Transnational Corp.
* Research & Development RA SA Argentina
* Research Dynamics Consulting Group, Ltd.
* Scian Research Services
* Scirex Corporation
* SFBC International
* SMO-USA, Inc.
* Southern Clinical & Regulatory, Inc.
* Stiris Research -Canada
* Stone Consultores
* Symbion Research International
* Synergos, Inc.
* Synteract, Inc.
* Target Health Inc.
* TERRE Clinical Research Services, Inc.
* TherImmune Research Corporation
* TKL Research, Inc.
* Trial Management Group, Inc.
* TrialStar, Inc.
* ViroMed Laboratories
* VPDC, Inc.
* Washington Biotechnology, Inc.
Europe
* ASCOpharm Paris, France
* Aster Cephac France
* Biodata Services ApS
* Bio-Kinetic Europe, Ltd. Belfast, North Ireland
* Biotrial Rennes and Paris
* C &T Paradigm Belgium
* CEPHA s.r.o. Czech Republic
* ClinResearch, GmbH
* Clintria Central Europe
* ClinTrial Ltd Hungary
* Cognatec Research Centre Northwest England
* CORONIS Research SA Greece
* CTO Clinical Trial Operations Netherlands
* d-Target Swiss clinical research organization
* DW Coordinatg Center Russia&Eastn Europe
* EpiStat Group, Inc. Eastern Europe
* Euphamed
* FOCUS Clinical Drug Development Germany
* FOVEA Group France
* HungaroTrial Hungary
* IFE Baltic, UAB Vilnius, Lithuania
* Imro Tramarko Contract Research Organisation
* Independent Clinical Research Consulting (ICRC) - German
* Independent Research and Laboratory Solutions - Greece
* Institut fuer Klinische Pharmokologie GmbH (IKP)
* Intercern Clinical Research
* IST GmbH Mannheim, Germany
* K.A. Seldeslagh & Associates (Kasa)
* Kriger Research Center Inc - European Union
* Kriger Research Center Inc - Eastern Europe
* Meddoc ApS - Scandinavian full service CRO
* Medical Statistics Consultancy
* Medico Chemical Lab
* Medicon A/S - Denmark
* Monipol Poland
* NorthWise Services
* Nottingham Clinical Research Group
* PFC Pharma Focus Switzerland and Germany
* Pharm PlanNet Germany
* Pharmalog - Institute for Clinical Research Germany
* PharmaPart AG Zürich
* Phase 1 CTU Ltd. United Kingdom
* PhaVista - German CRO
* PSI Pharma Support Inc Operating in Central Europe, Russia
* Radwan Clinical Research Center Polish CRO
* Remedium Clinical Research - Scandinavia and the Baltic states
* Rotrimen - Romanian CRO
* Russian Clinical Trials CRO, Russia
* Scope International Hamburg, Germany
* Sedoc Pharmaceutical Medicine AB Stockholm, Sweden
* SiteSupport - Denmark
* Spadille ApS
* Squarepoint-Pointcarré
* Swiss Pharma Contract
* Synexus, Ltd. UK
* TNO BIBRA International Ltd.
* UniMR Bulgaria
* Urodoc Limited UK
* VALID-TRIO GmbH
Asia, Pacific
* APEX International Clinical Research Co., Ltd.
* Asian Clinical Trials - India
* Catalyst Clinical Services India
* Gleneagles CRC SMO in Singapore
* Kansai Research Institute Japan
* Kriger Research Center Inc - Israel
* Kriger Research Center Inc - India
* Kriger Research Center Inc - Western Pacific
* Metrics Research-Pakistan
* Monitor Medical Research and Consulting -Turkey
* Protech Pharmaservices Corporation (PPC)
* Siro ClinPharm Pvt Ltd
* Synchron ResearchServicesPvt. Ltd.IndianCRO
Dr. Ausiello is a nationally recognized leader in academic medicine, who has made significant contributions to epithelial biology, particularly in the areas of membrane protein trafficking, ion channel regulation, and signal transduction. Dr. Ausiello received his undergraduate degree from Harvard College and his MD from the University of Pennsylvania. Since 1996, Dr. Ausiello has served as Chief of the Massachusetts General Hospital (MGH) Renal Unit, one of the most sought after research and training programs in the world.
He is the architect and director of the recently implemented Harvard Initiative in Patient-Associated Science: Training, Education, Understanding, and Research (PASTEUR). This program was designed to introduce Harvard medical students and select Harvard undergraduates and graduate students to patient-oriented research and to cultivate the development of the next generation of reflective physician-scientists.
Dr. Ausiello has received two MERIT awards from the National Institutes of Health and has served on the National Institute of Diabetes, Digestive, and Kidney Diseases Advisory Council and the National Advisory Council on Aging. He was elected to the Institute of Medicine of the National Academy of Science in 1999 and the American Academy of Arts and Sciences in 2003.
He is the co-editor of Cecil's Textbook of Medicine, now in its 23rd edition, and has been published in The New York Times, The Wall Street Journal, and The Boston Globe on topics ranging from human genetics to the relationship between the academics and industry.
Ms. Giusti founded the Multiple Myeloma Research Foundation (MMRF )in 1998, shortly after being diagnosed with multiple myeloma, an incurable blood cancer. The MMRF funds innovative myeloma research and drug discovery. She then founded the Multiple Myeloma Research Consortium (MMRC) in 2004 to enable leading research institutions to work with industry to speed the discovery and development of effective new treatments for myeloma.
Prior to her position at MMRF and MMRC, she served as Executive Director of G.D. Searle & Company’s worldwide arthritis franchise. She also worked for Merck & Company and the Gillette Company.
Kathy has been recognized for her work on behalf of multiple myeloma research. She has received the 1998 Healthcare Businesswomen's Association's Woman of the Year Award, the 2001 Harvard Business School Entrepreneurial Award, the 2002 McCarty Cancer Foundation Humanitarian Award, the 2002 Joseph Michaeli Award from the Weill Medical College of Cornell University, the 2005 Harvard Business School Award for Courage and Valor, and the 2006 Partners in Progress Award from the American Society of Clinical Oncology.
Kathy has served on the Institute of Medicine's National Cancer Policy Board and the Cancer Leadership Council. She currently is a member of the Health Research Alliance and serves on the National Cancer Advisory Board (appointed to the position by President Bush) and the Board of Directors for IMS Health. Most recently, Kathy's efforts to advance cancer research and drug development have been featured in The Wall Street Journal and on NBC Nightly News.
She holds an MBA in general management from the Harvard Business School.
DIA 44th Annual Meeting BOSTOM MA JUNE 2008
making the world a better place
International Pharmaceutical Publishers
